Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

The brief Dimensional Apathy Scale: A short clinical assessment of apathy.

Radakovic R, McGrory S, Chandran S, Swingler R, Pal S, Stephenson L, Colville S, Newton J, Starr JM, Abrahams S.

Clin Neuropsychol. 2019 Jun 3:1-13. doi: 10.1080/13854046.2019.1621382. [Epub ahead of print]

PMID:
31154933
2.

Clinical audit research and evaluation of motor neuron disease (CARE-MND): a national electronic platform for prospective, longitudinal monitoring of MND in Scotland.

Leighton D, Newton J, Colville S, Bethell A, Craig G, Cunningham L, Flett M, Fraser D, Hatrick J, Lennox H, Marshall L, McAleer D, McEleney A, Millar K, Silver A, Stephenson L, Stewart S, Storey D, Stott G, Thornton C, Webber C, Gordon H, Melchiorre G, Sherlock L, Beswick E, Buchanan D, Abrahams S, Bateman A, Preston J, Duncan C, Davenport R, Gorrie G, Morrison I, Swingler R, Chandran S, Pal S.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 May;20(3-4):242-250. doi: 10.1080/21678421.2019.1582673. Epub 2019 Mar 20.

PMID:
30889975
3.

Improved survival and 30-day mortality after gastrostomy in Scottish motor neurone disease patients: evidence from a national retrospective cohort study using STROBE criteria.

Gorrie GH, Chandran S, Colville S, Newton J, Leighton D, Mcdonald M, Pal S, Forbes R, Hair M, Swingler R.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 May;20(3-4):165-171. doi: 10.1080/21678421.2019.1570271. Epub 2019 Mar 5.

PMID:
30835562
4.

Changing epidemiology of motor neurone disease in Scotland.

Leighton DJ, Newton J, Stephenson LJ, Colville S, Davenport R, Gorrie G, Morrison I, Swingler R, Chandran S, Pal S; CARE-MND Consortium.

J Neurol. 2019 Apr;266(4):817-825. doi: 10.1007/s00415-019-09190-7. Epub 2019 Feb 25.

PMID:
30805795
5.

ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS.

Crockford C, Newton J, Lonergan K, Chiwera T, Booth T, Chandran S, Colville S, Heverin M, Mays I, Pal S, Pender N, Pinto-Grau M, Radakovic R, Shaw CE, Stephenson L, Swingler R, Vajda A, Al-Chalabi A, Hardiman O, Abrahams S.

Neurology. 2018 Oct 9;91(15):e1370-e1380. doi: 10.1212/WNL.0000000000006317. Epub 2018 Sep 12.

6.

Synapse loss in the prefrontal cortex is associated with cognitive decline in amyotrophic lateral sclerosis.

Henstridge CM, Sideris DI, Carroll E, Rotariu S, Salomonsson S, Tzioras M, McKenzie CA, Smith C, von Arnim CAF, Ludolph AC, Lulé D, Leighton D, Warner J, Cleary E, Newton J, Swingler R, Chandran S, Gillingwater TH, Abrahams S, Spires-Jones TL.

Acta Neuropathol. 2018 Feb;135(2):213-226. doi: 10.1007/s00401-017-1797-4. Epub 2017 Dec 22.

7.

Multidimensional apathy and executive dysfunction in amyotrophic lateral sclerosis.

Radakovic R, Stephenson L, Newton J, Crockford C, Swingler R, Chandran S, Abrahams S.

Cortex. 2017 Sep;94:142-151. doi: 10.1016/j.cortex.2017.06.023. Epub 2017 Jul 13.

PMID:
28759804
8.

Corrigendum to "Genetic epidemiology of motor neuron disease-associated variants in the Scottish population." [Neurobiol. Aging 51 (2017) 178.e11-178.e20].

Black HA, Leighton DJ, Cleary EM, Rose E, Stephenson L, Colville S, Ross D, Warner J, Porteous M, Gorrie GH, Swingler R, Goldstein D, Harms MB, Connick P, Pal S, Aitman TJ, Chandran S.

Neurobiol Aging. 2017 Aug;56:214. doi: 10.1016/j.neurobiolaging.2017.04.019. No abstract available.

9.

Genetic epidemiology of motor neuron disease-associated variants in the Scottish population.

Black HA, Leighton DJ, Cleary EM, Rose E, Stephenson L, Colville S, Ross D, Warner J, Porteous M, Gorrie GH, Swingler R, Goldstein D, Harms MB, Connick P, Pal S, Aitman TJ, Chandran S.

Neurobiol Aging. 2017 Mar;51:178.e11-178.e20. doi: 10.1016/j.neurobiolaging.2016.12.013. Epub 2016 Dec 21. Erratum in: Neurobiol Aging. 2017 Aug;56:214.

10.

Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis.

van Rheenen W, Shatunov A, Dekker AM, McLaughlin RL, Diekstra FP, Pulit SL, van der Spek RA, Võsa U, de Jong S, Robinson MR, Yang J, Fogh I, van Doormaal PT, Tazelaar GH, Koppers M, Blokhuis AM, Sproviero W, Jones AR, Kenna KP, van Eijk KR, Harschnitz O, Schellevis RD, Brands WJ, Medic J, Menelaou A, Vajda A, Ticozzi N, Lin K, Rogelj B, Vrabec K, Ravnik-Glavač M, Koritnik B, Zidar J, Leonardis L, Grošelj LD, Millecamps S, Salachas F, Meininger V, de Carvalho M, Pinto S, Mora JS, Rojas-García R, Polak M, Chandran S, Colville S, Swingler R, Morrison KE, Shaw PJ, Hardy J, Orrell RW, Pittman A, Sidle K, Fratta P, Malaspina A, Topp S, Petri S, Abdulla S, Drepper C, Sendtner M, Meyer T, Ophoff RA, Staats KA, Wiedau-Pazos M, Lomen-Hoerth C, Van Deerlin VM, Trojanowski JQ, Elman L, McCluskey L, Basak AN, Tunca C, Hamzeiy H, Parman Y, Meitinger T, Lichtner P, Radivojkov-Blagojevic M, Andres CR, Maurel C, Bensimon G, Landwehrmeyer B, Brice A, Payan CA, Saker-Delye S, Dürr A, Wood NW, Tittmann L, Lieb W, Franke A, Rietschel M, Cichon S, Nöthen MM, Amouyel P, Tzourio C, Dartigues JF, Uitterlinden AG, Rivadeneira F, Estrada K, Hofman A, Curtis C, Blauw HM, van der Kooi AJ, de Visser M, Goris A, Weber M, Shaw CE, Smith BN, Pansarasa O, Cereda C, Del Bo R, Comi GP, D'Alfonso S, Bertolin C, Sorarù G, Mazzini L, Pensato V, Gellera C, Tiloca C, Ratti A, Calvo A, Moglia C, Brunetti M, Arcuti S, Capozzo R, Zecca C, Lunetta C, Penco S, Riva N, Padovani A, Filosto M, Muller B, Stuit RJ; PARALS Registry; SLALOM Group; SLAP Registry; FALS Sequencing Consortium; SLAGEN Consortium; NNIPPS Study Group, Blair I, Zhang K, McCann EP, Fifita JA, Nicholson GA, Rowe DB, Pamphlett R, Kiernan MC, Grosskreutz J, Witte OW, Ringer T, Prell T, Stubendorff B, Kurth I, Hübner CA, Leigh PN, Casale F, Chio A, Beghi E, Pupillo E, Tortelli R, Logroscino G, Powell J, Ludolph AC, Weishaupt JH, Robberecht W, Van Damme P, Franke L, Pers TH, Brown RH, Glass JD, Landers JE, Hardiman O, Andersen PM, Corcia P, Vourc'h P, Silani V, Wray NR, Visscher PM, de Bakker PI, van Es MA, Pasterkamp RJ, Lewis CM, Breen G, Al-Chalabi A, van den Berg LH, Veldink JH.

Nat Genet. 2016 Sep;48(9):1043-8. doi: 10.1038/ng.3622. Epub 2016 Jul 25.

11.

Improved PCR based methods for detecting C9orf72 hexanucleotide repeat expansions.

Cleary EM, Pal S, Azam T, Moore DJ, Swingler R, Gorrie G, Stephenson L, Colville S, Chandran S, Porteous M, Warner JP.

Mol Cell Probes. 2016 Aug;30(4):218-224. doi: 10.1016/j.mcp.2016.06.001. Epub 2016 Jun 7.

12.

Multidimensional apathy in ALS: validation of the Dimensional Apathy Scale.

Radakovic R, Stephenson L, Colville S, Swingler R, Chandran S, Abrahams S.

J Neurol Neurosurg Psychiatry. 2016 Jun;87(6):663-9. doi: 10.1136/jnnp-2015-310772. Epub 2015 Jul 22.

13.

Validation of the Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen (ECAS): A cognitive tool for motor disorders.

Niven E, Newton J, Foley J, Colville S, Swingler R, Chandran S, Bak TH, Abrahams S.

Amyotroph Lateral Scler Frontotemporal Degener. 2015 Jun;16(3-4):172-9. doi: 10.3109/21678421.2015.1030430. Epub 2015 May 12.

14.

Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study.

Al-Chalabi A, Calvo A, Chio A, Colville S, Ellis CM, Hardiman O, Heverin M, Howard RS, Huisman MHB, Keren N, Leigh PN, Mazzini L, Mora G, Orrell RW, Rooney J, Scott KM, Scotton WJ, Seelen M, Shaw CE, Sidle KS, Swingler R, Tsuda M, Veldink JH, Visser AE, van den Berg LH, Pearce N.

Lancet Neurol. 2014 Nov;13(11):1108-1113. doi: 10.1016/S1474-4422(14)70219-4. Epub 2014 Oct 7.

15.

The novel MAPT mutation K298E: mechanisms of mutant tau toxicity, brain pathology and tau expression in induced fibroblast-derived neurons.

Iovino M, Pfisterer U, Holton JL, Lashley T, Swingler RJ, Calo L, Treacy R, Revesz T, Parmar M, Goedert M, Muqit MM, Spillantini MG.

Acta Neuropathol. 2014 Feb;127(2):283-95. doi: 10.1007/s00401-013-1219-1. Epub 2013 Nov 30.

16.

ANO5 gene analysis in a large cohort of patients with anoctaminopathy: confirmation of male prevalence and high occurrence of the common exon 5 gene mutation.

Sarkozy A, Hicks D, Hudson J, Laval SH, Barresi R, Hilton-Jones D, Deschauer M, Harris E, Rufibach L, Hwang E, Bashir R, Walter MC, Krause S, van den Bergh P, Illa I, Pénisson-Besnier I, De Waele L, Turnbull D, Guglieri M, Schrank B, Schoser B, Seeger J, Schreiber H, Gläser D, Eagle M, Bailey G, Walters R, Longman C, Norwood F, Winer J, Muntoni F, Hanna M, Roberts M, Bindoff LA, Brierley C, Cooper RG, Cottrell DA, Davies NP, Gibson A, Gorman GS, Hammans S, Jackson AP, Khan A, Lane R, McConville J, McEntagart M, Al-Memar A, Nixon J, Panicker J, Parton M, Petty R, Price CJ, Rakowicz W, Ray P, Schapira AH, Swingler R, Turner C, Wagner KR, Maddison P, Shaw PJ, Straub V, Bushby K, Lochmüller H.

Hum Mutat. 2013 Aug;34(8):1111-8. doi: 10.1002/humu.22342. Epub 2013 Jun 12.

PMID:
23606453
17.

Not hysteria: ovarian teratoma-associated anti-N-methyl-D-aspartate receptor encephalitis.

Roberts R, MacDougall NJ, O'Brien P, Abdelaziz K, Christie J, Swingler R.

Scott Med J. 2012 Aug;57(3):182. doi: 10.1258/smj.2012.012026.

PMID:
22859813
18.

What a difference an egg makes.

Fisher RA, Lavery SA, Carby A, Abu-Hayyeh S, Swingler R, Sebire NJ, Seckl MJ.

Lancet. 2011 Dec 3;378(9807):1974. doi: 10.1016/S0140-6736(11)61751-0. Epub 2011 Nov 28. No abstract available.

PMID:
22130487
19.

Delayed presentation of invasive thymoma in myasthenia gravis: a case report.

Galizia EC, Farrugia ME, Swingler R.

Neuromuscul Disord. 2011 Apr;21(4):279-81. doi: 10.1016/j.nmd.2011.01.002. Epub 2011 Feb 5.

PMID:
21296574
20.

Use of intravenous immunoglobulin in the Department of Neurology at Ninewells Hospital, 2008-2009: Indications for utilization and cost-effectiveness.

O' Riordan J, Swingler RJ, Malek NM.

Ann Indian Acad Neurol. 2010 Oct;13(4):271-5. doi: 10.4103/0972-2327.74199.

21.

The epidemiology and treatment of ALS: focus on the heterogeneity of the disease and critical appraisal of therapeutic trials.

Beghi E, Chiò A, Couratier P, Esteban J, Hardiman O, Logroscino G, Millul A, Mitchell D, Preux PM, Pupillo E, Stevic Z, Swingler R, Traynor BJ, Van den Berg LH, Veldink JH, Zoccolella S; Eurals Consortium.

Amyotroph Lateral Scler. 2011 Jan;12(1):1-10. doi: 10.3109/17482968.2010.502940. Epub 2010 Aug 11. Review.

22.

The prognosis of motor neurone disease.

Swingler RJ.

J Neurol Neurosurg Psychiatry. 2010 Oct;81(10):1062. doi: 10.1136/jnnp.2010.206888. Epub 2010 Jul 2. No abstract available.

PMID:
20601670
23.

Primary care access to computed tomography for chronic headache.

Thomas R, Cook A, Main G, Taylor T, Galizia Caruana E, Swingler R.

Br J Gen Pract. 2010 Jun;60(575):426-30. doi: 10.3399/bjgp10X502146.

24.

Amyotrophic lateral sclerosis, physical exercise, trauma and sports: results of a population-based pilot case-control study.

Beghi E, Logroscino G, Chiò A, Hardiman O, Millul A, Mitchell D, Swingler R, Traynor BJ.

Amyotroph Lateral Scler. 2010 May 3;11(3):289-92. doi: 10.3109/17482960903384283.

25.

Evaluation of a dedicated teaching gynaecology clinic.

Swingler R, Platt S, Glew SS.

Med Educ. 2010 May;44(5):498. doi: 10.1111/j.1365-2923.2010.03645.x. Epub 2010 Mar 30. No abstract available.

PMID:
20374462
26.

Prognostic factors in ALS: A critical review.

Chiò A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, Traynor BG; Eurals Consortium.

Amyotroph Lateral Scler. 2009 Oct-Dec;10(5-6):310-23. doi: 10.3109/17482960802566824. Review.

27.

Dopamine dysregulation syndrome in a patient with early onset Parkinsonism and Parkin gene mutations.

Sammler EM, Swingler RJ, Stuart A, Muqit M.

Mov Disord. 2009 Dec 15;24(16):2442-3. doi: 10.1002/mds.22859. No abstract available.

PMID:
19891003
28.

Incidence of amyotrophic lateral sclerosis in Europe.

Logroscino G, Traynor BJ, Hardiman O, Chiò A, Mitchell D, Swingler RJ, Millul A, Benn E, Beghi E; EURALS.

J Neurol Neurosurg Psychiatry. 2010 Apr;81(4):385-90. doi: 10.1136/jnnp.2009.183525. Epub 2009 Aug 25.

29.

Cause of death and clinical grading criteria in a cohort of amyotrophic lateral sclerosis cases undergoing autopsy from the Scottish Motor Neurone Disease Register.

Kurian KM, Forbes RB, Colville S, Swingler RJ.

J Neurol Neurosurg Psychiatry. 2009 Jan;80(1):84-7. doi: 10.1136/jnnp.2008.149708.

PMID:
19091712
30.

Increasing prevalence and incidence of multiple sclerosis in South East Wales.

Hirst C, Ingram G, Pickersgill T, Swingler R, Compston DA, Robertson NP.

J Neurol Neurosurg Psychiatry. 2009 Apr;80(4):386-91. doi: 10.1136/jnnp.2008.144667. Epub 2008 Oct 17.

PMID:
18931003
31.

Advanced glaucomatous visual loss and oral steroids.

Chadha V, Cruickshank I, Swingler R, Sanders R.

BMJ. 2008 Aug 1;337:a670. doi: 10.1136/bmj.a670. No abstract available.

PMID:
18676441
32.

50bp deletion in the promoter for superoxide dismutase 1 (SOD1) reduces SOD1 expression in vitro and may correlate with increased age of onset of sporadic amyotrophic lateral sclerosis.

Broom WJ, Greenway M, Sadri-Vakili G, Russ C, Auwarter KE, Glajch KE, Dupre N, Swingler RJ, Purcell S, Hayward C, Sapp PC, McKenna-Yasek D, Valdmanis PN, Bouchard JP, Meininger V, Hosler BA, Glass JD, Polack M, Rouleau GA, Cha JH, Hardiman O, Brown RH Jr.

Amyotroph Lateral Scler. 2008 Aug;9(4):229-37. doi: 10.1080/17482960802103107.

PMID:
18608091
33.

A patient suffering from hypokalemic periodic paralysis is deficient in skeletal muscle ATP-sensitive K channels.

Jovanović S, Du Q, Mukhopadhyay S, Swingler R, Buckley R, McEachen J, Jovanović A.

Clin Transl Sci. 2008 May;1(1):71-4. doi: 10.1111/j.1752-8062.2008.00007.x.

34.

Survival and cause of death in multiple sclerosis: a prospective population-based study.

Hirst C, Swingler R, Compston DA, Ben-Shlomo Y, Robertson NP.

J Neurol Neurosurg Psychiatry. 2008 Sep;79(9):1016-21. doi: 10.1136/jnnp.2007.127332. Epub 2008 Feb 26.

PMID:
18303108
35.

Change in disability in patients with multiple sclerosis: a 20-year prospective population-based analysis.

Hirst C, Ingram G, Swingler R, Compston DA, Pickersgill T, Robertson NP.

J Neurol Neurosurg Psychiatry. 2008 Oct;79(10):1137-43. doi: 10.1136/jnnp.2007.133785. Epub 2008 Feb 26.

PMID:
18303106
36.

The heterogeneity of amyotrophic lateral sclerosis: a possible explanation of treatment failure.

Beghi E, Mennini T, Bendotti C, Bigini P, Logroscino G, Chiò A, Hardiman O, Mitchell D, Swingler R, Traynor BJ, Al-Chalabi A.

Curr Med Chem. 2007;14(30):3185-200. Review.

PMID:
18220753
37.

Chlamydia pneumoniae-specific serum immune complexes in patients with multiple sclerosis.

Parratt J, Tavendale R, O'Riordan J, Parratt D, Swingler R.

Mult Scler. 2008 Apr;14(3):292-9. doi: 10.1177/1352458507083188. Epub 2008 Jan 21.

PMID:
18208884
38.

Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues.

Logroscino G, Traynor BJ, Hardiman O, Chio' A, Couratier P, Mitchell JD, Swingler RJ, Beghi E; EURALS.

J Neurol Neurosurg Psychiatry. 2008 Jan;79(1):6-11. Review.

PMID:
18079297
39.

Amyotrophic lateral sclerosis and soccer: a different epidemiological approach strengthen the previous findings.

Chiò A, Traynor BJ, Swingler R, Mitchell D, Hardiman O, Mora G, Beghi E, Logroscino G; EURALS consortium.

J Neurol Sci. 2008 Jun 15;269(1-2):187-8; author reply 188-9. Epub 2007 Nov 8. No abstract available.

PMID:
17996254
40.

Effect of referral bias on assessing survival in als.

Logroscino G, Beghi E, Hardiman O, Chio A, Mitchell JD, Swingler RJ, Traynor B; EURALS.

Neurology. 2007 Aug 28;69(9):939; author reply 939-40. No abstract available.

PMID:
17724304
41.

Neurodevelopmental outcome at 5 years after operative delivery in the second stage of labor: a cohort study.

Bahl R, Patel RR, Swingler R, Ellis M, Murphy DJ.

Am J Obstet Gynecol. 2007 Aug;197(2):147.e1-6.

PMID:
17689628
42.

The incidence of motor nueron disease in Scotland.

Forbes RB, Colville S, Parratt J, Swingler RJ.

J Neurol. 2007 Jul;254(7):866-9. Epub 2007 Apr 10.

PMID:
17420925
43.

A population based study of respiratory function in motor neuron disease patients living in Tayside and North East Fife, Scotland.

Colville S, Swingler RJ, Grant IS, Williams FL.

J Neurol. 2007 Apr;254(4):453-8. Epub 2007 Mar 31.

PMID:
17401524
44.

Re: "antibiotic use and risk of multiple sclerosis".

Parratt JD, O'Riordan JI, Swingler RJ, Parratt D.

Am J Epidemiol. 2006 Dec 15;164(12):1253; author reply 1253-4. Epub 2006 Nov 9. No abstract available.

PMID:
17095537
45.

The epidemiology of ALS and the role of population-based registries.

Beghi E, Logroscino G, Chiò A, Hardiman O, Mitchell D, Swingler R, Traynor BJ; EURALS Consortium.

Biochim Biophys Acta. 2006 Nov-Dec;1762(11-12):1150-7. Epub 2006 Sep 29. Review. No abstract available.

46.

ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis.

Greenway MJ, Andersen PM, Russ C, Ennis S, Cashman S, Donaghy C, Patterson V, Swingler R, Kieran D, Prehn J, Morrison KE, Green A, Acharya KR, Brown RH Jr, Hardiman O.

Nat Genet. 2006 Apr;38(4):411-3. Epub 2006 Feb 26.

PMID:
16501576
47.

Multiple sclerosis in Tayside, Scotland: detection of clusters using a spatial scan statistic.

Donnan PT, Parratt JD, Wilson SV, Forbes RB, O'Riordan JI, Swingler RJ.

Mult Scler. 2005 Aug;11(4):403-8.

PMID:
16042222
48.

Controversial treatments for spinal-cord injuries.

Swingler RJ.

Lancet. 2005 Mar 5-11;365(9462):841-2. No abstract available.

PMID:
15752518
49.

Unexpected decline in survival from amyotrophic lateral sclerosis/motor neurone disease.

Forbes RB, Colville S, Cran GW, Swingler RJ; Scottish Motor Neurone Disease Register.

J Neurol Neurosurg Psychiatry. 2004 Dec;75(12):1753-5.

50.

Pelvic floor morbidity up to one year after difficult instrumental delivery and cesarean section in the second stage of labor: a cohort study.

Liebling RE, Swingler R, Patel RR, Verity L, Soothill PW, Murphy DJ.

Am J Obstet Gynecol. 2004 Jul;191(1):4-10.

PMID:
15295337

Supplemental Content

Loading ...
Support Center